BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15807878)

  • 1. Final adult height and body mass index after cure of paediatric Cushing's disease.
    Davies JH; Storr HL; Davies K; Monson JP; Besser GM; Afshar F; Plowman PN; Grossman AB; Savage MO
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):466-72. PubMed ID: 15807878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome.
    Savage MO; Lienhardt A; Lebrethon MC; Johnston LB; Huebner A; Grossman AB; Afshar F; Plowman PN; Besser GM
    Horm Res; 2001; 55 Suppl 1():24-30. PubMed ID: 11408758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth in disorders of adrenal hyperfunction.
    Savage MO; Scommegna S; Carroll PV; Ho JT; Monson JP; Besser GM; Grossman AB
    Horm Res; 2002; 58 Suppl 1():39-43. PubMed ID: 12373013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear growth and final height after treatment for Cushing's disease in childhood.
    Lebrethon MC; Grossman AB; Afshar F; Plowman PN; Besser GM; Savage MO
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3262-5. PubMed ID: 10999819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF; McNeill E; Young D; Donaldson MD
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
    Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia.
    Storr HL; Mitchell H; Swords FM; Main KM; Hindmarsh PC; Betts PR; Shaw NJ; Johnston DI; Clark AJ; Reznek RH; Grossman AB; Savage MO
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):553-9. PubMed ID: 15521956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.
    Storr HL; Plowman PN; Carroll PV; François I; Krassas GE; Afshar F; Besser GM; Grossman AB; Savage MO
    J Clin Endocrinol Metab; 2003 Jan; 88(1):34-7. PubMed ID: 12519825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
    Bajpai A; Kabra M; Gupta AK; Menon PS
    Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency.
    Schmidt H; Bechtold S; Schwarz HP
    Eur J Med Res; 2000 Jul; 5(7):307-10. PubMed ID: 10903191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D; Meazza C; Cardinale GM; Farinelli E; Mastrangelo C; Messini B; Citro G; Del Vecchio M; Di Maio S; Possenti I; Bozzola M
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
    Mouat F; Hofman PL; Jefferies C; Gunn AJ; Cutfield WS
    Clin Endocrinol (Oxf); 2009 May; 70(5):751-6. PubMed ID: 19178517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
    Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth and growth hormone secretion in paediatric Cushing's disease.
    Savage MO; Storr HL; Grossman AB; Krassas GE
    Hormones (Athens); 2003; 2(2):93-7. PubMed ID: 17003007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).
    Binder G; Iliev DI; Mullis PE; Ranke MB
    Growth Horm IGF Res; 2007 Jun; 17(3):242-8. PubMed ID: 17360215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
    Rachmiel M; Rota V; Atenafu E; Daneman D; Hamilton J
    Horm Res; 2007; 68(5):236-43. PubMed ID: 17396034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome.
    Binder G; Trebar B; Baur F; Schweizer R; Ranke MB
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):567-72. PubMed ID: 17973940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
    Trollmann R; Bakker B; Lundberg M; Doerr HG
    Pediatr Rehabil; 2006; 9(2):144-8. PubMed ID: 16449073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.